| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 5e-05 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -3.1e-05 | 1 |